ORKA

Oruka Therapeutics, Inc. Common Stock

33.40

USD

ORKA Earnings Reports

Positive Surprise Ratio

ORKA beat 15 of 16 last estimates.

94%

Next Report

Date of Next Report

Mar 04, 2026

Estimate for Q4 25 (Revenue/ EPS)

-$0.65

Implied change from Q3 25 (Revenue/ EPS)

+18.18%

Implied change from Q4 24 (Revenue/ EPS)

+32.65%

Oruka Therapeutics, Inc. Common Stock earnings per share and revenue

On Nov 12, 2025, ORKA reported earnings of -0.55 USD per share (EPS) for Q3 25, beating the estimate of -0.59 USD, resulting in a 7.27% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -6.78% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 13 analysts forecast an EPS of -0.65 USD, with revenue projected to reach -- USD, implying an increase of 18.18% EPS, and increase of 0.00% in Revenue from the last quarter.

FAQ

What were Oruka Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Oruka Therapeutics, Inc. Common Stock reported EPS of -$0.55, beating estimates by 7.27%, and revenue of $0.00, 0% as expectations.

How did the market react to Oruka Therapeutics, Inc. Common Stock's Q3 2025 earnings?

The stock price moved down -6.78%, changed from $28.30 before the earnings release to $26.38 the day after.

When is Oruka Therapeutics, Inc. Common Stock expected to report next?

The next earning report is scheduled for Mar 04, 2026.

What are the forecasts for Oruka Therapeutics, Inc. Common Stock's next earnings report?

Based on 13 analysts, Oruka Therapeutics, Inc. Common Stock is expected to report EPS of -$0.65 and revenue of -- for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.